Home / Business and Economy / Bayer Sells Contraceptives Stake for €3 Billion
Bayer Sells Contraceptives Stake for €3 Billion
10 Jul
Summary
- Bayer AG divested a minority stake in its contraceptives division.
- The deal with Apollo Global Management Inc. is valued at €3 billion.
- Funds raised will bolster Bayer's capital structure significantly.
Bayer AG has successfully divested a minority stake in its contraceptives business, securing a significant €3 billion ($3.4 billion) from Apollo Global Management Inc. This strategic financial maneuver is poised to enhance Bayer's overall capital structure.
The German multinational corporation, known for its diverse operations in pharmaceuticals and crop science, confirmed that it will maintain complete operational oversight of the contraceptives division. This ensures that business continues without disruption.
The infusion of capital is a key objective for Bayer, aiming to reinforce its financial health and flexibility. The company plans to allocate these funds strategically to achieve its capital improvement goals.
